US advisers urge higher bar for new diabetes drugs

SILVER SPRING, Md. (Reuters Life!) - U.S. regulators should require drugmakers to study the potential heart risks of all new diabetes medicines, an advisory panel said on Wednesday.

Continue to US advisers urge higher bar for new diabetes drugs on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz